These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

937 related items for PubMed ID: 3104117

  • 1. The virtual elimination of rubella and mumps from the United States and the use of combined measles, mumps and rubella vaccines (MMR) to eliminate measles.
    Bart KJ, Orenstein WA, Hinman AR.
    Dev Biol Stand; 1986; 65():45-52. PubMed ID: 3104117
    [Abstract] [Full Text] [Related]

  • 2. Measles, mumps and rubella: control by vaccination.
    van Druten JA, de Boo T, Plantinga AD.
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [Abstract] [Full Text] [Related]

  • 3. Vaccination with a combined vaccine against measles, mumps and rubella aiming at elimination of the three diseases.
    Böttiger M, Christenson B, Strandell A, Romanus V.
    Dev Biol Stand; 1986; 65():37-43. PubMed ID: 3556776
    [Abstract] [Full Text] [Related]

  • 4. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W.
    Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387
    [Abstract] [Full Text] [Related]

  • 5. Combination measles, mumps, rubella and varicella vaccine.
    Arbeter AM, Baker L, Starr SE, Levine BL, Books E, Plotkin SA.
    Pediatrics; 1986 Oct; 78(4 Pt 2):742-7. PubMed ID: 3763291
    [Abstract] [Full Text] [Related]

  • 6. The measles-mumps-rubella vaccination program in Finland.
    Lerman SJ.
    N Engl J Med; 1995 Apr 20; 332(16):1103. PubMed ID: 7898541
    [No Abstract] [Full Text] [Related]

  • 7. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V, Cantell K.
    N Engl J Med; 1994 Nov 24; 331(21):1397-402. PubMed ID: 7969278
    [Abstract] [Full Text] [Related]

  • 8. The measles-mumps-rubella vaccination program in Finland.
    Redd SC, Wharton M, Hadler SC, Orenstein WA.
    N Engl J Med; 1995 Apr 20; 332(16):1102-3. PubMed ID: 7898540
    [No Abstract] [Full Text] [Related]

  • 9. ACIP issues recommendations to eliminate measles, rubella and congenital rubella syndrome and to control mumps.
    Rose VL.
    Am Fam Physician; 1998 Nov 01; 58(7):1682, 1685-6. PubMed ID: 9824963
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Watson JC, Hadler SC, Dykewicz CA, Reef S, Phillips L.
    MMWR Recomm Rep; 1998 May 22; 47(RR-8):1-57. PubMed ID: 9639369
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E, Tischer A.
    Gesundheitswesen; 1993 Jan 22; 55(1):38-9. PubMed ID: 8435543
    [Abstract] [Full Text] [Related]

  • 15. Mumps incidence in Israel--impact of MMR vaccine.
    Slater PE, Roitman M, Costin C.
    Public Health Rev; 1993 Jan 22; 18(1):88-93. PubMed ID: 2132885
    [Abstract] [Full Text] [Related]

  • 16. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K, Nicoara C, Germann D, Matter L.
    Schweiz Med Wochenschr; 1998 Apr 25; 128(17):649-57. PubMed ID: 9622837
    [Abstract] [Full Text] [Related]

  • 17. [Clinico-immunologic evaluation of a trivalent vaccine against measles, rubella and mumps].
    Schettini F, Manzionna MM, De Mattia D, Amendola F, Di Bitonto G.
    Minerva Pediatr; 1989 Mar 25; 41(3):117-22. PubMed ID: 2747598
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States.
    Zhou F, Reef S, Massoudi M, Papania MJ, Yusuf HR, Bardenheier B, Zimmerman L, McCauley MM.
    J Infect Dis; 2004 May 01; 189 Suppl 1():S131-45. PubMed ID: 15106102
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.